ESR1 and breast cancer: ESRRA has been most studied in the context of breast cancer: it is a negative prognostic marker in ER(–) tumors [14],[15], and it induces VEGF mRNA expression and contributes to the malignant phenotype of a breast cancer cell line [16],[17].